Verve Surges After FDA Lifts Hold on Gene-Editing Therapy
Verve Therapeutics Inc. surged in premarket trading after US drug regulators lifted their hold on the company’s application
2023-10-23 20:29
PIF-Backed Medical Procurement Firm Nupco Plans Saudi IPO
Saudi Arabia’s sovereign wealth fund is exploring an initial public offering of the kingdom’s largest medical procurement firm,
2023-10-23 16:58
Philips Lifts Outlook on Continued Supply-Chain Improvement
Royal Philips NV raised its full-year outlook after supply-chain constraints eased to give some breathing room to the
2023-10-23 13:55
Merck Discontinues Developing Drug Candidates With Sichuan Kelun After Daiichi Sankyo Deal
Merck & Co. won’t continue with two drug candidates it previously agreed to co-develop with a Chinese biotech
2023-10-23 13:50
Australia Gender Bias Costs Economy $80 Billion, Taskforce Says
Australia needs urgent legislative changes to end economic inequality between men and women, a government taskforce found, highlighting
2023-10-23 11:55
When Japan Ends Negative Rate Policy, Treasuries Will Suffer
Japan’s era of negative interest rates will end in coming months, and the implications for world markets will
2023-10-23 08:52
After a robust third quarter, US economic growth will likely slow. That bodes well for rate cuts next year.
The Commerce Department is set to report third-quarter gross domestic product Thursday. It's the broadest measure of economic output, and it'll likely show that the US economy expanded at a staggeringly rapid pace from July through September, despite higher interest rates, depleted pandemic savings and high inflation.
2023-10-22 20:16
Roche Taps AI to Find Lung Cancer Patients After Trial Success
Roche Holding AG’s lung cancer drug scored a big win against a standard therapy in a study this
2023-10-21 17:20
Investors seek shelter as U.S. stocks grow more turbulent
By Lewis Krauskopf NEW YORK Growing volatility in U.S. stocks is driving a search for defensive assets, though
2023-10-21 07:20
Ozempic Fear in Food and Drink Stocks Has ‘Gone Overboard,’ RBC Says
The stocks rout fueled by the frenzy around a new class of weight-loss drugs is starting to make
2023-10-21 02:47
Medical device makers see limited hit from weight-loss drugs
U.S. medical device makers do not see a big impact of new weight-loss treatments on the sales of
2023-10-20 22:18
Factbox-Corporate America weighs risks of the Ozempic effect
U.S. companies across sectors such as food and beverage makers and manufacturers of glucose monitors have faced investor
2023-10-20 10:55